Trial Profile
Comparison of tiotropium and ipratropium in a double-blind, double-dummy, efficacy and safety study in adults with COPD [chronic obstructive pulmonary disease]
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Mar 2007
Price :
$35
*
At a glance
- Drugs Ipratropium bromide (Primary) ; Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 27 Mar 2007 New trial record.